Grupo Nutresa S. A Valuation

Is NUTRESACL undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

2/6

Valuation Score 2/6

Below Fair Value
Significantly Below Fair Value
Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of NUTRESACL when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: NUTRESACL (CLP10290) is trading below our estimate of fair value (CLP28314.38)

Significantly Below Fair Value: NUTRESACL is trading below fair value by more than 20%.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for NUTRESACL?

Key metric: As NUTRESACL is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.

The above table shows the Price to Earnings ratio for NUTRESACL. This is calculated by dividing NUTRESACL's market cap by their current earnings.
What is NUTRESACL's PE Ratio?
PE Ratio	59.9x
Earnings	Col$607.84b
Market Cap	Col$36.39t

NUTRESACL key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenue	2.3x
Enterprise Value/EBITDA	18.4x
PEG Ratio	n/a

Price to Earnings Ratio vs Peers

How does NUTRESACL's PE Ratio compare to its peers?

The above table shows the PE ratio for NUTRESACL vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
Company	Forward PE	Estimated Growth	Market Cap
Peer Average	17.9x
AQUACHILE Empresas AquaChile	5.4x	n/a	CL$985.0b
CAROZZI Carozzi	5.9x	n/a	CL$557.7b
WATTS Watt's	9.8x	n/a	CL$214.4b
SALMOCAM Salmones Camanchaca	50.6x	65.6%	CL$175.5b
NUTRESACL Grupo Nutresa S. A	59.9x	n/a	CL$36.4t

Price-To-Earnings vs Peers: NUTRESACL is expensive based on its Price-To-Earnings Ratio (59.9x) compared to the peer average (17.9x).

Price to Earnings Ratio vs Industry

How does NUTRESACL's PE Ratio compare vs other companies in the South American Food Industry?

2 Companies	Price / Earnings	Estimated Growth	Market Cap

2 Companies		Estimated Growth	Market Cap

No more companies

Price-To-Earnings vs Industry: NUTRESACL is expensive based on its Price-To-Earnings Ratio (59.9x) compared to the South American Food industry average (9.9x).

Price to Earnings Ratio vs Fair Ratio

What is NUTRESACL's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

NUTRESACL PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio	59.9x
Fair PE Ratio	n/a

Price-To-Earnings vs Fair Ratio: Insufficient data to calculate NUTRESACL's Price-To-Earnings Fair Ratio for valuation analysis.

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Analyst Forecast: Insufficient data to show price forecast.

Discover undervalued companies

Duncan Fox

CL$105.0b

Engages in the agro-industrial, hotel, and real estate businesses in Chile.

DUNCANFOX

CL$1,050.00

23.5%

Carozzi

CL$557.7b

Produces and markets food products in Chile.

CAROZZI

CL$2,500.00

51.5%

Viña San Pedro Tarapacá

CL$151.9b

Produces and exports wines in Chile, Argentina, and internationally.

VSPT

CL$3.80

-15.6%

-31.3%